| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Fatty Liver; Non-alcoholic Fatty Liver Disease | Phase 2 | ClinicalTrials |
| Hypercholesterolemia; Hyperlipoproteinemia Type II | Phase 2 | ClinicalTrials |
| Fatty Liver; Non-alcoholic Fatty Liver Disease | Phase 3 | ClinicalTrials |
CONTENTS